e-learning
resources
Barcelona 2010
Monday, 20.09.2010
Aetiology of lower respiratory tract infections and treatment in special situations
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Community acquired pneumonia in Greece: Clinical, microbiological data and adherence to the IDSA guidelines
C. Triantafyllidis, V. Kapordelis, D. Orfanidou, M. Apostolidou, I. Nikolopoulos, G. Petrikkos, A. Pefanis (Athens, Greece)
Source:
Annual Congress 2010 - Aetiology of lower respiratory tract infections and treatment in special situations
Session:
Aetiology of lower respiratory tract infections and treatment in special situations
Session type:
Thematic Poster Session
Number:
3008
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
C. Triantafyllidis, V. Kapordelis, D. Orfanidou, M. Apostolidou, I. Nikolopoulos, G. Petrikkos, A. Pefanis (Athens, Greece). Community acquired pneumonia in Greece: Clinical, microbiological data and adherence to the IDSA guidelines. Eur Respir J 2010; 36: Suppl. 54, 3008
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Related content which might interest you:
Community acquired pneumonia in Greece: clinical, laboratory data – adherence to the international guidelines
Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia
Year: 2007
Community acquired pneumonia in a Greek hospital: Adherence of Greek doctors to the IDSA/ATS and national guidelines
Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia
Year: 2011
Community acquired pneumonia guidelines: not only treatment indications
Source: Annual Congress 2004 - PG22 - New perspectives in pneumonia treatment and prophylaxis
Year: 2004
The implementation of IDSA/ATS and the Greek national guidelines for CAP by chest physicians in Greece
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016
The adherence of Greek chest physicians to the 2007 IDSA/ATS and the Greek national guidelines for CAP
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013
From international guidelines to local guidelines for nosocomial pneumonia: what is missing?
Source: International Congress 2019 – Multidrug resistance in nosocomial pneumonia: burden, magnitude and solution
Year: 2019
Implementation of IDSA/ATS and national guidelines for community acquired pneumonia by Greek chest phycisians
Source: Annual Congress 2012 - Management of pneumonia due to hospital pathogens
Year: 2012
The compliance of Greek chest physicians with IDSA/ATS and the Greek national guidelines for CAP
Source: International Congress 2014 – Different interesting issues in respiratory infections: 1
Year: 2014
Simplifying IDSA/ATS pneumonia guidelines
Source: Annual Congress 2013 –Viral infections: what is new?
Year: 2013
Results of nationwide performance measurement programme for community-acquired pneumonia in German federal state Hessen in 2012
Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer
Year: 2014
Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia
Source: Guideline 2018
Year: 2019
Summary of the international clinical guidelines for the management of hospital-acquired and ventilator-acquired pneumonia
Source: ERJ Open Res, 4 (2) 00028-2018; 10.1183/23120541.00028-2018
Year: 2018
European Respiratory Society clinical practice guidelines: methodological guidance
Source: ERJ Open Res, 8 (1) 00655-2021; 10.1183/23120541.00655-2021
Year: 2022
International Guideline concordance of empiric antibiotic use in community-acquired pneumonia
Source: Virtual Congress 2020 – Antibiotic therapy for pneumonia and pleural infections
Year: 2020
Quality of care in bronchiectasis using the European Respiratory Society Guidelines as a reference standard- data from the EMBARC registry
Source: Virtual Congress 2021 – Respiratory infections and bronchiectasis outcomes
Year: 2021
The Bronchiectasis Research Registry: Clinical, microbiologic, and treatment characteristics
Source: Annual Congress 2010 - COPD: diagnosis
Year: 2010
Performance of immune-based and microbiological tests in children with tuberculosis meningitis in Europe: a multicentre Paediatric Tuberculosis Network European Trials Group (ptbnet) study
Source: Eur Respir J, 56 (1) 1902004; 10.1183/13993003.02004-2019
Year: 2020
Antibiotic therapy of community-acquired pneumonia in the hospital setting: national guidelines and real clinical practice.
Source: International Congress 2017 – COPD management
Year: 2017
Call for urgent actions to ensure access to early diagnosis and care of tuberculosis among refugees: Statement of the European Respiratory Society and the European Region of the International Union Against Tuberculosis and Lung Disease
Source: Eur Respir J 2016; 47:1345-1347
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept